Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface
Open Access
- 1 February 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (2) , 336-346
- https://doi.org/10.1111/j.1538-7836.2007.02308.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The use of recombinant factor VIIa in the treatment of bleeding disordersBlood, 2004
- Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancementBiochemical Journal, 2004
- Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia ABlood, 2003
- Influence of Factor VIIa and Phospholipids on Coagulation in “Acquired” HemophiliaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Response: Mechanism of Action of High-Dose Factor VIIaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Tissue Factor Residues Lys165 and Lys166 Are Essential for Rapid Formation of the Quaternary Complex of Tissue Factor.cntdot.VIIa with Xa.cntdot.Tissue Factor Pathway InhibitorBiochemistry, 1995
- Tissue factor pathway inhibitor and the current concept of blood coagulationBlood Coagulation & Fibrinolysis, 1995
- Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factorThrombosis Research, 1988
- A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.Journal of Clinical Investigation, 1984
- Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucosideBiochemistry, 1981